Abstract:Recent studies have sparked renewed interest in the therapeutic potential of psychedelics for treating depression and other mental health conditions. Simultaneously, the novel psychoactive substances (NPS) phenomenon, with a huge number of NPS emerging constantly, has changed remarkably the illicit drug market, being their scientific evaluation an urgent need. Thus, this study aims to elucidate the impact of amino-terminal modifications to the 5-MeO-DMT molecule on its interactions with serotonin receptors and transporters, as well as its psychoactive and thermoregulatory properties. Our findings demonstrated, using radioligand binding methodologies, that all examined 5-MeO-tryptamines exhibited selectivity for 5-HT1AR over 5-HT2AR. In fact, computational docking analyses predicted a better interaction in the 5-HT1AR binding pocket compared to 5-HT2AR. Our investigation also proved the interaction of these compounds with SERT, revealing that the molecular size of the amino group significantly influenced their affinity. Subsequent experiments involving serotonin uptake, electrophysiology, and superfusion release assays confirmed 5-MeO-pyr-T as the most potent partial 5-HT releaser tested. All tested tryptamines elicited, to some degree, the head twitch response (HTR) in mice, indicative of a potential hallucinogenic effect and mainly mediated by 5-HT2AR activation. However, 5-HT1AR was also shown to be implicated in the hallucinogenic effect, and its activation attenuated the HTR. In fact, tryptamines that produced a higher hypothermic response, mediated by 5-HT1AR, tended to exhibit a lower hallucinogenic effect, highlighting the opposite role of both 5-HT receptors. Moreover, although some 5-MeO-tryptamines elicited very low HTR, they still act as potent 5-HT2AR agonists. In summary, this research offers a comprehensive understanding of the psychopharmacological profile of various amino-substituted 5-MeO-tryptamines, keeping structural aspects in focus and accumulating valuable data in the frame of NPS. Moreover, the unique characteristics of some 5-MeO-tryptamines render them intriguing molecules as mixed-action drugs and provide insight within the search of non-hallucinogenic but 5-HT2AR ligands as therapeutical agents.

What problem does this paper attempt to address?

The problems that this paper attempts to solve mainly focus on the following aspects: 1. **Clarifying the structure - activity relationship**: The research aims to reveal the influence of these modifications on the pharmacological properties of drugs by systematically exploring the influence of amino - terminal modification of 5 - MeO - DMT molecules on their interactions with serotonin receptors (especially 5 - HT1A and 5 - HT2A receptors) and serotonin transporters (SERT). Specifically, the researchers hope to experimentally verify the selectivity of these compounds on different receptors and their ability as serotonin releasers or inhibitors. 2. **Evaluating the psychoactive and thermoregulatory properties**: In addition to in vitro experiments, the research also evaluates the psychoactive effects of these compounds (such as the head - twitch response HTR, an index often used to evaluate hallucinogenic effects) and their influence on the core body temperature of mice through in vivo experiments, so as to fully understand the physiological effects of these compounds. 3. **Exploring the roles of 5 - HT1A and 5 - HT2A receptors in the hallucinogenic effect**: The research further explores the specific contributions of 5 - HT1A and 5 - HT2A receptors in the hallucinogenic effects of these compounds, especially the opposite effects of these two receptors in regulating body temperature and hallucinogenic effects. 4. **Research on new psychoactive substances**: In view of the rapid increase in new psychoactive substances (NPS) in recent years, this study also aims to provide scientific evaluation for this type of substances and accumulate valuable data, especially the research on the structure - activity relationship within the NPS framework. Through the above research objectives, this paper hopes to provide a theoretical basis for the future development of non - hallucinogenic but 5 - HT2A receptor - active therapeutic drugs and deepen the understanding of the pharmacological properties of 5 - MeO - DMT derivatives.

Structure-activity relationships of serotonergic 5-MeO-DMT derivatives: insights into psychoactive and thermoregulatory properties

Structural Insights into Tryptamine Psychedelics: the Role of Hydroxyl Indole Ring Site in 5-HT2A Receptor Activation and Psychedelic-like Activity

Structure–Activity Relationship and Evaluation of Phenethylamine and Tryptamine Derivatives for Affinity towards 5-Hydroxytryptamine Type 2A Receptor

Synthesis And Characterization Of 5-Hydroxy-2-(2-Phenylethyl)Chromone (5-Hpec) And Its Analogues As Non-Nitrogenous 5-Ht2b Ligands

Discovery and Structure-Activity Relationships of 2,5-Dimethoxyphenylpiperidines as Selective Serotonin 5-HT 2A Receptor Agonists

Evaluation of the Indazole Analogs of 5-MeO-DMT and Related Tryptamines as Serotonin Receptor 2 Agonists

Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials

Pharmacological and behavioural effects of tryptamines present in psilocybin‐containing mushrooms

Neurochemical characterization of 5-HT2AR partial agonists with simultaneous PET-MRI

Effect of Bulky N -Dibenzofuranylmethyl Substitution on the 5-HT 2 Receptor Affinity and Efficacy of a Psychedelic Phenethylamine

Use of the head-twitch response to investigate the structure-activity relationships of 4-thio-substituted 2,5-dimethoxyphenylalkylamines

Uncovering Structure–Activity Relationships of Phenethylamines: Paving the Way for Innovative Mental Health Treatments

Molecular insights into the modulation of the 5HT2A receptor by serotonin, psilocin, and the G protein subunit Gqalpha

Dimethyltryptamine and other hallucinogenic tryptamines exhibit substrate behavior at the serotonin uptake transporter and the vesicle monoamine transporter

The selective 5-HT receptor agonist LPH-5 induces persistent and robust antidepressant-like effects in rodents

Evaluation of TrpM and PsiD substrate promiscuity reveals new biocatalytic capabilities

Serotonergic Psychedelics – a Comparative review Comparing the Efficacy, Safety, Pharmacokinetics and Binding Profile of Serotonergic Psychedelics

Investigation of the 2,5-Dimethoxy Motif in Phenethylamine Serotonin 2A Receptor Agonists

Molecular and Medical Aspects of Psychedelics

Exploration of 1-(4-(7-Azaindole)-3,6-dihydropyridin-1-yl)alkyl-3-(1H-indol-3-yl)pyrrolidine-2,5-dione Derivatives with Affinity for the Serotonin Transporter

Serotonergic psychedelic 5-MeO-DMT alters plasticity-related gene expression and generates anxiolytic effects in stressed mice